Author:
Jager Nynke G.L.,Linn Sabine C.,Schellens Jan H.M.,Beijnen Jos H.
Reference43 articles.
1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.; Lyon, France: International Agency for Research on Cancer, 2013.
2. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen;Shiau;Cell,1998
3. Aromatase inhibitors in breast cancer;Smith;N Engl J Med,2003
4. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013
5. aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer (abstract 5);Gray;J Clin Oncol,2013
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献